From Hospital Admission to Home: New Standards for Extended Duration VTE Prophylaxis in Acutely Ill Medical Patients
Sunday, April 8
5:30 – 7:30 p.m., Canary Room 1-2
Dinner provided at 5:30 p.m.
Learning Objective: To educate on the risk of VTE in acutely ill medical patients, APEX clinical trial results, and Bevyxxa (betrixaban).
Overview:
- Review the burden of VTE in acutely ill medical patients.
- Provide an overview of the unmet need for extended-duration VTE prophylaxis from hospital admission to home.
- Review the APEX clinical trial data.
- Provide an overview of Bevyxxa (betrixaban) indication, safety information, dosing, and appropriate patient types.
Presenter: Hameed Ali, DO, FHM, clinical assistant professor of medicine and hospitalist, Baylor Scott and White Health Hospital, Temple, Tex.
This program is supported by Portola Pharmaceuticals.
Reducing COPD-related Readmissions through Individualized Maintenance Therapy and Increased Patient Engagement
Sunday, April 8
5:30 – 7:30 p.m., Canary Room 3-4
Dinner provided at 5:30 p.m.
Overview: Hospitals are a critical point of intervention in the care pathway of chronic obstructive pulmonary disease (COPD). Clinicians in this setting must be well versed in current treatment guidelines, as well as the full spectrum of medications and delivery devices, to provide disease management tailored to the physical and cognitive needs of each patient. Moreover, hospital clinicians also need to be adept at communicating with patients and engaging them in the management of their own disease. Collectively, these measures can significantly reduce symptom severity and the risk for future exacerbations, increase physical activity, and improve overall quality of life in patients with COPD. This program will improve the knowledge and competence of clinicians who care for patients with COPD.
Learning objectives: Upon completion of this educational activity, participants should be able to:
- Identify long-term treatment strategies to reduce hospital readmissions for COPD exacerbations.
- Review the clinical evidence regarding the efficacy and safety of long-acting maintenance regimens for COPD.
- Select medication delivery devices for patients with COPD based upon individual physical and cognitive characteristics.
- Outline a transitional care plan that promotes patient self-management to reduce the risk for future exacerbations and hospital readmissions.
Presenters: Stanley B. Fiel, MD, regional chair in the department of medicine, Atlantic Health System, and the deNeufville Professor, chairman of the department of medicine, Morristown (NJ) Medical Center; José Luis González, MD, assistant professor of internal medicine, department of internal medicine, University of Southern California, and primary care physician, department of primary care, LAC+USC Medical Center, Los Angeles.
Accreditation statement: Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit designation: Integrity Continuing Education, Inc. designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.